Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Struthers Richard Scott
President & CEO at Crinetics Pharmaceuticals. Filing since 15 Jul 2020.
CIK 0001746298
Company
Date
Role
Action
Shares
Amount
Of holding
CRNX
Crinetics Pharmaceuticals, Inc.
16 Mar 2026
President & CEO
Sold on a plan
21,981
$821.51K
5.2%
CRNX
Crinetics Pharmaceuticals, Inc.
26 Sep 2025
President & CEO
Sold on a plan
4,000
$180.00K
3.6%
CRNX
Crinetics Pharmaceuticals, Inc.
19 Mar 2025
President & CEO
Sold on a plan
17,338
$593.02K
5.0%
CRNX
Crinetics Pharmaceuticals, Inc.
2 Dec 2024
President & CEO
Sold on a plan
10,000
$575.70K
9.1%
CRNX
Crinetics Pharmaceuticals, Inc.
8 May 2024
President & CEO
Sold on a plan
107,448
$5.31M
29.4%
CRNX
Crinetics Pharmaceuticals, Inc.
4 Apr 2024
President & CEO
Sold on a plan
40,951
$2.01M
14.7%
CRNX
Crinetics Pharmaceuticals, Inc.
3 Nov 2023
President & CEO
Sold on a plan
199,082
$6.08M
59.5%
CRNX
Crinetics Pharmaceuticals, Inc.
2 Nov 2023
President & CEO
Sold on a plan
918
$27.49K
0.7%
CRNX
Crinetics Pharmaceuticals, Inc.
13 Jul 2023
President & CEO
Sold on a plan
14,157
$288.09K
2.2%
CRNX
Crinetics Pharmaceuticals, Inc.
12 Jul 2023
President & CEO
Sold on a plan
11,459
$231.13K
1.7%
CRNX
Crinetics Pharmaceuticals, Inc.
11 Jul 2023
President & CEO
Sold on a plan
24,384
$491.09K
3.6%
CRNX
Crinetics Pharmaceuticals, Inc.
16 Jun 2023
President & CEO
Sold on a plan
50,000
$1.04M
6.8%
CRNX
Crinetics Pharmaceuticals, Inc.
13 Apr 2022
President & CEO
Sold, plan not stated
138,643
$3.72M
15.9%
CRNX
Crinetics Pharmaceuticals, Inc.
5 Apr 2022
President & CEO
Sold, plan not stated
21,357
$541.22K
2.4%
CRNX
Crinetics Pharmaceuticals, Inc.
7 Sep 2021
President & CEO
Sold, plan not stated
30,000
$750.00K
25.0%
CRNX
Crinetics Pharmaceuticals, Inc.
3 Dec 2020
President & CEO
Bought
4,000
$52.40K
opened
CRNX
Crinetics Pharmaceuticals, Inc.
2 Dec 2020
President & CEO
Bought
1,000
$12.60K
opened
CRNX
Crinetics Pharmaceuticals, Inc.
16 Jul 2020
President & CEO
Sold, plan not stated
17,500
$253.11K
1.9%
CRNX
Crinetics Pharmaceuticals, Inc.
15 Jul 2020
President & CEO
Sold, plan not stated
17,500
$267.72K
1.9%
19 decisions on file.
